380 related articles for article (PubMed ID: 32289351)
21. Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent's disease.
Raggi C; Fujiwara K; Leal T; Jouret F; Devuyst O; Terryn S
Pflugers Arch; 2011 Dec; 462(6):851-60. PubMed ID: 21927812
[TBL] [Abstract][Full Text] [Related]
22. Dent's disease.
Devuyst O; Thakker RV
Orphanet J Rare Dis; 2010 Oct; 5():28. PubMed ID: 20946626
[TBL] [Abstract][Full Text] [Related]
23. Nephrolithiasis, kidney failure and bone disorders in Dent disease patients with and without CLCN5 mutations.
Anglani F; D'Angelo A; Bertizzolo LM; Tosetto E; Ceol M; Cremasco D; Bonfante L; Addis MA; Del Prete D;
Springerplus; 2015; 4():492. PubMed ID: 26389017
[TBL] [Abstract][Full Text] [Related]
24. Dent disease: A window into calcium and phosphate transport.
Anglani F; Gianesello L; Beara-Lasic L; Lieske J
J Cell Mol Med; 2019 Nov; 23(11):7132-7142. PubMed ID: 31472005
[TBL] [Abstract][Full Text] [Related]
25. Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis.
Novarino G; Weinert S; Rickheit G; Jentsch TJ
Science; 2010 Jun; 328(5984):1398-401. PubMed ID: 20430975
[TBL] [Abstract][Full Text] [Related]
26. Impaired Endosome Maturation Mediates Tubular Proteinuria in Dent Disease Cell Culture and Mouse Models.
Shipman KE; Baty CJ; Long KR; Rbaibi Y; Cowan IA; Gerges M; Marciszyn AL; Kashlan OB; Tan RJ; Edwards A; Weisz OA
J Am Soc Nephrol; 2023 Apr; 34(4):619-640. PubMed ID: 36758125
[TBL] [Abstract][Full Text] [Related]
27. Dent disease in Poland: what we have learned so far?
Zaniew M; Mizerska-Wasiak M; Załuska-Leśniewska I; Adamczyk P; Kiliś-Pstrusińska K; Haliński A; Zawadzki J; Lipska-Ziętkiewicz BS; Pawlaczyk K; Sikora P; Ludwig M; Szczepańska M
Int Urol Nephrol; 2017 Nov; 49(11):2005-2017. PubMed ID: 28815356
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic spectrum and antialbuminuric response to angiotensin converting enzyme inhibitor and angiotensin receptor blocker therapy in pediatric Dent disease.
Deng H; Zhang Y; Xiao H; Yao Y; Zhang H; Liu X; Su B; Guan N; Zhong X; Wang S; Ding J; Wang F
Mol Genet Genomic Med; 2020 Aug; 8(8):e1306. PubMed ID: 32495484
[TBL] [Abstract][Full Text] [Related]
29. Severe Osteomalacia with Dent Disease Caused by a Novel Intronic Mutation of the CLCN5 gene.
Matsumoto A; Matsui I; Mori T; Sakaguchi Y; Mizui M; Ueda Y; Takahashi A; Doi Y; Shimada K; Yamaguchi S; Kubota K; Hashimoto N; Oka T; Takabatake Y; Sohara E; Hamano T; Uchida S; Isaka Y
Intern Med; 2018 Dec; 57(24):3603-3610. PubMed ID: 30101934
[TBL] [Abstract][Full Text] [Related]
30. Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA: genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria.
Sekine T; Komoda F; Miura K; Takita J; Shimadzu M; Matsuyama T; Ashida A; Igarashi T
Nephrol Dial Transplant; 2014 Feb; 29(2):376-84. PubMed ID: 24081861
[TBL] [Abstract][Full Text] [Related]
31. ClC-5: Physiological role and biophysical mechanisms.
Pusch M; Zifarelli G
Cell Calcium; 2015 Jul; 58(1):57-66. PubMed ID: 25443653
[TBL] [Abstract][Full Text] [Related]
32. Conformational defects underlie proteasomal degradation of Dent's disease-causing mutants of ClC-5.
D'Antonio C; Molinski S; Ahmadi S; Huan LJ; Wellhauser L; Bear CE
Biochem J; 2013 Jun; 452(3):391-400. PubMed ID: 23566014
[TBL] [Abstract][Full Text] [Related]
33. Dent disease 1-linked novel CLCN5 mutations result in aberrant location and reduced ion currents.
Wang Y; Xu L; Zhang Y; Fu H; Gao L; Guan Y; Gu W; Sun J; Chen X; Yang F; Lai E; Wang J; Jin Y; Kou Z; Qiu X; Mao J; Hu L
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128564. PubMed ID: 38061527
[TBL] [Abstract][Full Text] [Related]
34. Renal antiporter ClC-5 regulates collagen I/IV through the β-catenin pathway and lysosomal degradation.
Durán M; Ariceta G; Semidey ME; Castells-Esteve C; Casal-Pardo A; Lu B; Meseguer A; Cantero-Recasens G
Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38670633
[TBL] [Abstract][Full Text] [Related]
35. A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5.
Okamoto T; Tajima T; Hirayama T; Sasaki S
Eur J Pediatr; 2012 Feb; 171(2):401-4. PubMed ID: 21932010
[TBL] [Abstract][Full Text] [Related]
36. Can we generate new hypotheses about Dent's disease from gene analysis of a mouse model?
Guggino SE
Exp Physiol; 2009 Feb; 94(2):191-6. PubMed ID: 18931044
[TBL] [Abstract][Full Text] [Related]
37. Establishment of an induced pluripotent stem cell line (NCKDi003-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p. T277P (c. 829A > C) in the CLCN5 gene.
Hu L; Wang G; Wu H; Fu H; Wang Y; Yu F; Liu Z; Mao J
Stem Cell Res; 2021 Oct; 56():102538. PubMed ID: 34547705
[TBL] [Abstract][Full Text] [Related]
38. Four additional CLCN5 exons encode a widely expressed novel long CLC-5 isoform but fail to explain Dent's phenotype in patients without mutations in the short variant.
Ludwig M; Waldegger S; Nuutinen M; Bökenkamp A; Reissinger A; Steckelbroeck S; Utsch B
Kidney Blood Press Res; 2003; 26(3):176-84. PubMed ID: 12886045
[TBL] [Abstract][Full Text] [Related]
39. The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces a euthyroid goiter in the mouse thyroid gland.
van den Hove MF; Croizet-Berger K; Jouret F; Guggino SE; Guggino WB; Devuyst O; Courtoy PJ
Endocrinology; 2006 Mar; 147(3):1287-96. PubMed ID: 16306076
[TBL] [Abstract][Full Text] [Related]
40. ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells.
Günther W; Lüchow A; Cluzeaud F; Vandewalle A; Jentsch TJ
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8075-80. PubMed ID: 9653142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
